Erika Jensen-Jarolim

Title: The Innovative Contributions of Erika Jensen-Jarolim

Introduction

Erika Jensen-Jarolim is a prominent inventor based in Vienna, Austria. She has made significant contributions to the field of allergy diagnosis and treatment. With a total of 7 patents to her name, her work has had a profound impact on medical science.

Latest Patents

One of her latest patents is a method and means for diagnosing and treating allergies. This innovative method involves measuring the level of species-specific lipocalin, particularly lipocalin 2, in a sample from a human or animal patient. A lowered level of this lipocalin compared to a control sample indicates the presence of an allergy. Additionally, she has developed kits for performing this method and for quality control of allergen molecules or extracts used in immunotherapy. These kits determine the siderophore-iron ligand load, which is crucial for assessing immunomodulatory potency. Furthermore, her research includes lipocalin proteins that can be used in the treatment or prevention of allergies, preferably when complexed with siderophore-iron ligands.

Career Highlights

Throughout her career, Erika has worked with Biomedical International R + D GmbH, where she has furthered her research and development efforts in allergy treatment. Her innovative approaches have positioned her as a leader in her field.

Collaborations

Erika has collaborated with notable colleagues such as Franziska Roth-Walter and Christoph Zielinski. These partnerships have enhanced her research and contributed to her success in the field of allergy diagnostics.

Conclusion

Erika Jensen-Jarolim's contributions to allergy diagnosis and treatment exemplify her dedication to medical innovation. Her patents and collaborative efforts continue to influence the field positively.